Abstract: The invention relates to compounds of formula (I): and their pharmaceutically acceptable salts and solvates, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.
Type:
Application
Filed:
December 4, 2009
Publication date:
January 12, 2012
Applicant:
PROMIMAGEN LTD.
Inventors:
Marianne Nilsson, Martin Haraldsson, Sofia Henriksson, Rikard Emond, Edward Daniel Savory, Iain David Simpson